Next Article in Journal
A Novel Neotropical Bacillus siamensis Strain Inhibits Soil-Borne Plant Pathogens and Promotes Soybean Growth
Previous Article in Journal
Evidence of Malodorous Chloroanisoles in “Mold Houses” Was Omitted When Indoor Air Research Evolved
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Editorial for the Gut Microbiota Section

by
Pramod K. Gopal
1,2
1
The New Zealand Institute for Plant and Food Research Limited (PFR), Private Bag 11600, Palmerston North 4442, New Zealand
2
Riddet Institute, Massey University, Palmerston North 4410, New Zealand
Microorganisms 2025, 13(6), 1364; https://doi.org/10.3390/microorganisms13061364
Submission received: 5 June 2025 / Accepted: 10 June 2025 / Published: 12 June 2025
(This article belongs to the Section Gut Microbiota)
The gut microbiota—a diverse and dynamic consortium of trillions of microorganisms inhabiting the gastrointestinal tract—plays a pivotal role in host health across species. As the scientific community continues to uncover the profound influence of the gut microbiome on host physiology, we stand at the forefront of a transformative era in biomedical research. From metabolic regulation and immune system modulation to neurobehavioral outcomes, the gut microbiota has emerged as a central determinant of both health and disease.
In this context, we are pleased to invite researchers, clinicians, and interdisciplinary scientists to contribute to the Gut Microbiota section of Microorganisms, a platform dedicated to advancing the frontiers of microbiome science.
We welcome submissions of original research articles, systematic reviews, meta-analyses, and short communications that investigate:
  • Novel microbial mechanisms and pathways relevant to both human and animal health;
  • Therapeutic strategies, including next-generation probiotics and prebiotics, as well as faecal microbial transplantation;
  • Host–microbiome interactions across physiological systems and species;
  • Microbiome-based diagnostics and precision medicine approaches.
Submissions should be grounded in robust methodology and offer clear mechanistic insights or translational relevance. We particularly encourage contributions that incorporate multi-omics technologies, computational modelling, or clinical trial data, as well as studies addressing microbiome diversity across populations and environments.
All manuscripts will undergo a rigorous peer-review process. We emphasise transparency, reproducibility, and adherence to the highest standards of ethical research.
Join us in shaping the future of microbiome science and contributing to a growing body of knowledge that supports microbiota-informed solutions for improved health and well-being.

Conflicts of Interest

The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gopal, P.K. Editorial for the Gut Microbiota Section. Microorganisms 2025, 13, 1364. https://doi.org/10.3390/microorganisms13061364

AMA Style

Gopal PK. Editorial for the Gut Microbiota Section. Microorganisms. 2025; 13(6):1364. https://doi.org/10.3390/microorganisms13061364

Chicago/Turabian Style

Gopal, Pramod K. 2025. "Editorial for the Gut Microbiota Section" Microorganisms 13, no. 6: 1364. https://doi.org/10.3390/microorganisms13061364

APA Style

Gopal, P. K. (2025). Editorial for the Gut Microbiota Section. Microorganisms, 13(6), 1364. https://doi.org/10.3390/microorganisms13061364

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop